Loading...
XTAE
EFNC-M
Market cap1mUSD
Aug 15, Last price  
261.30ILS
Name

Erech Finance Cahalacha Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
2,350.74
EPS
—
Div Yield, %
—
Shrs. gr., 5y
15.94%
Rev. gr., 5y
-50.83%
Revenues
282k
-97.35%
121,000571,000195,00083,00040,0009,808,0006,592,00010,070,00013,390,00010,649,000282,000
Net income
-25m
L+1.01%
-28,276,000-47,339,000-15,766,000-8,947,000-7,014,000-10,300,000-6,779,0001,345,0001,024,000-25,040,000-25,293,000
CFO
-2m
L-53.88%
-22,227,000-40,309,000-20,561,000-9,994,000-7,681,000-330,000532,000-6,791,000-8,952,000-4,716,000-2,175,000

Profile

Erech Finance Cahalacha Ltd, together with its subsidiaries, provides loans and credit services to small and medium sized enterprises, associations, and individual borrowers in Israel. It operates through Non-Bank Credit and Biomed Drug segments. The company is also involved in the development of drugs in the areas of diabetes and cancer. Erech Finance Cahalacha Ltd is based in Jerusalem, Israel.
URL
https://www.insuline-medical.com/
IPO date
Aug 04, 2010
Employees
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
282
-97.35%
10,649
-20.47%
Cost of revenue
6,275
8,536
Unusual Expense (Income)
NOPBT
(5,993)
2,113
NOPBT Margin
19.84%
Operating Taxes
5,442
(3,617)
Tax Rate
NOPAT
(11,435)
5,730
Net income
(25,293)
1.01%
(25,040)
-2,545.31%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
12,653
39,058
Long-term debt
4,316
160
Deferred revenue
Other long-term liabilities
12,957
89
Net debt
15,360
37,256
Cash flow
Cash from operating activities
(2,175)
(4,716)
CAPEX
(15)
Cash from investing activities
503
(714)
Cash from financing activities
FCF
(22,212)
5,721
Balance
Cash
1,609
1,962
Long term investments
Excess cash
1,595
1,430
Stockholders' equity
(55,131)
28,366
Invested Capital
89,390
66,243
ROIC
7.29%
ROCE
3.12%
EV
Common stock shares outstanding
2,537
2,537
Price
4.64
-24.56%
6.15
-81.97%
Market cap
11,767
-24.56%
15,597
-79.22%
EV
27,127
52,369
EBITDA
(5,984)
2,119
EV/EBITDA
24.71
Interest
2,012
2,356
Interest/NOPBT
111.50%